Home › Research › Getting a diagnosis
Clinical practice guidelines on addressing cognitive impairment in treatable dementias
M Aleem Siddiqui, Shobit Garg, Sai Krishna Tikka. Indian Journal of Psychiatry, 2025-01-01
Topic: Risk, prevention and care in population studies
This is because of the ambiguity surrounding the terminology used to characterize reversible dementia—the variation in the population being studied, or the existence of subclinical instances that are difficult to diagnose.[3] By and large however, the proportion of reversible dementias compared to the irreversible dementias is very low. While, the prevalence of potentially reversible aetiology has been reported 18% in patients under the age of 65 years, however only 5% in those over 65 years.[3] A meta-analysis showed that although potentially reversible causes were seen in 9% of the cases, only 0.6% of dementia cases could be reversed.[4] Optimum assessment of differential diagnosis and prompt treatment are therefore of paramount importance. The team then determined the scope of the guideline in consultation with the clinical practice committee members, in particular to make sure there are no significant overlaps between the various guidelines of the issue. Tables 1a-1f show the list of disorders in each of the classified reversible dementia subtypes as mentioned above and their clinical features.Table 1a: Intracranial (neurosurgical) disorders and their clinical featuresTable 1b: Intracranial (neuroinfections) disorders and their clinical featuresTable 1c: Systemic (including metabolic/endocrinal) disorders and their clinical featuresTable 1d: Toxicity and their clinical featuresTable 1e: Drugs causing cognitive dysfunction and associated featuresTable 1f: Mental and behavioural disorders and their clinical featuresCLINICAL COURSE OF “TREATABLE DEMENTIAS” In this section, we briefly describe the course of some of the highly prevalent causes of “treatable dementia” below: Alcohol-induced (related) dementia Several lines of research suggest that chronic consumption of alcohol leads to permanent damage, both structural and functional, to the brain. Patients with ARD are mostly male, have their onset of symptoms younger compared to other dementias and lack social support. Although it may be difficult to diagnose depressive cognitive disorder when there is a significant overlap of depressive and true dementia symptoms, there are aspects that help differentiate it from true dementias. Similarly, hyperthyroidism is linked to an increased risk of Alzheimer’s disease brain pathology due to greater thyroxine levels; however, there is minimal evidence that treating these abnormalities may enhance cognition. This is because thyroid disease can result in other proble
Key findings
- This is because of the ambiguity surrounding the terminology used to characterize reversible dementia—the variation in the population being studied, or the existence of subclinical instances that are difficult to diagnose.[3] By and large however, the proportion of reversible dementias compared to the irreversible dementias is very low.
- While, the prevalence of potentially reversible aetiology has been reported 18% in patients under the age of 65 years, however only 5% in those over 65 years.[3] A meta-analysis showed that although potentially reversible causes were seen in 9% of the cases, only 0.6% of dementia cases could be reversed.[4] Optimum assessment of differential diagnosis and prompt treatment are therefore of paramount importance.
- The team then determined the scope of the guideline in consultation with the clinical practice committee members, in particular to make sure there are no significant overlaps between the various guidelines of the issue.
- Tables 1a-1f show the list of disorders in each of the classified reversible dementia subtypes as mentioned above and their clinical features.Table 1a: Intracranial (neurosurgical) disorders and their clinical featuresTable 1b: Intracranial (neuroinfections) disorders and their clinical featuresTable 1c: Systemic (including metabolic/endocrinal) disorders and their clinical featuresTable 1d: Toxicity and their clinical featuresTable 1e: Drugs causing cognitive dysfunction and associated featuresTable 1f: Mental and behavioural disorders and their clinical featuresCLINICAL COURSE OF “TREATABLE DEMENTIAS” In this section, we briefly describe the course of some of the highly prevalent causes of “treatable dementia” below: Alcohol-induced (related) dementia Several lines of research suggest that chronic consumption of alcohol leads to permanent damage, both structural and functional, to the brain.
- Patients with ARD are mostly male, have their onset of symptoms younger compared to other dementias and lack social support.
Why it matters
This guideline discusses the low proportion of reversible dementias and the importance of prompt assessment and treatment of potentially reversible causes. It focuses on clinical management of treatable dementias, not on treating, curing, or preventing Alzheimer's disease itself.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Study designmeta-analysis
- Effect size7.4%; 0.6%
- Evidence strengthHigh
How this study scored 56/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for sample size and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Indian Journal of Psychiatry) |
| Journal's citation record | 1 / 4 | Indian Journal of Psychiatry: journal h-index 94 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | A review of other studies — randomisation is not credited here |
| Times cited | 2 / 7 | Cited 6 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Sai Krishna Tikka: h-index 20 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Era's Lucknow Medical College and Hospital: institution h-index 69 (OpenAlex) |
| Multi-centre collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40046486) |
| Free to read | 2 / 2 | Free to read |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_684_24
- PubMed: 40046486
- Original source →
- Free full text: Indian Journal of Psychiatry →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Siddiqui, M. A., Garg, S., & Tikka, S. K. (2025). Clinical practice guidelines on addressing cognitive impairment in treatable dementias. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_684_24
Vancouver
Siddiqui MA, Garg S, Tikka SK. Clinical practice guidelines on addressing cognitive impairment in treatable dementias. Indian Journal of Psychiatry. 2025. doi:10.4103/indianjpsychiatry.indianjpsychiatry_684_24. PMID: 40046486.
BibTeX
@article{siddiqui2025-40046486,
author = {Siddiqui, M Aleem and Garg, Shobit and Tikka, Sai Krishna},
title = {{Clinical practice guidelines on addressing cognitive impairment in treatable dementias}},
journal = {Indian Journal of Psychiatry},
year = {2025},
doi = {10.4103/indianjpsychiatry.indianjpsychiatry_684_24},
pmid = {40046486},
url = {https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_684_24}
}
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Getting a diagnosis
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.